Safe Orthopaedics SA (SAFOR):企業の財務・戦略的SWOT分析

◆英語タイトル:Safe Orthopaedics SA (SAFOR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME378331FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Safe Orthopaedics SA (Safe Orthopaedics) is medical device company that manufactures and markets devices for spinal surgery. The company’s products comprise implants and surgical instruments. It also offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws, percutaneous auto-correction screws and leaner positioning cages. Safe Orthopaedics also provides pedicle screws and lumber cage instrument kits. It also offers screw angulation components for optimal fixation. Safe Orthopaedics’ instruments are used for the treatment of trauma and degenerative pathologies. The company markets its products through a network of distributors across Europe, South America, Africa and Australia. Safe Orthopaedics is headquartered in Paris, France

Safe Orthopaedics SA Key Recent Developments

Apr 08,2021: Safe Orthopaedics announces a €1,1M turnover for the first quarter of 2021 despite the Covid-19 sanitary crisis
Feb 10,2021: Safe Group and the american company SpineUp announce the signature of a technological co-development agreement
Jan 14,2021: Safe Orthopaedics announces a 3,8 M€ annual turnover for the group and gives an update on its bond financing line
Nov 05,2020: Safe Orthopaedics starts construction of its innovation and industrial production center in Fleurieux-sur-l’Arbresle
Oct 08,2020: Safe Orthopaedics announces its revenues for the third quarter of 2020 : €943k

This comprehensive SWOT profile of Safe Orthopaedics SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Safe Orthopaedics SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Safe Orthopaedics SA – Key Information
Safe Orthopaedics SA – Overview
Safe Orthopaedics SA – Key Employees
Safe Orthopaedics SA – Key Employee Biographies
Safe Orthopaedics SA – Key Operational Heads
Safe Orthopaedics SA – Major Products and Services
Safe Orthopaedics SA – History
Safe Orthopaedics SA – Company Statement
Safe Orthopaedics SA – Locations And Subsidiaries
Safe Orthopaedics SA
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Safe Orthopaedics SA – Business Description
Safe Orthopaedics SA – Corporate Strategy
Safe Orthopaedics SA – SWOT Analysis
SWOT Analysis – Overview
Safe Orthopaedics SA – Strengths
Safe Orthopaedics SA – Weaknesses
Safe Orthopaedics SA – Opportunities
Safe Orthopaedics SA – Threats
Safe Orthopaedics SA – Key Competitors

Section 3 – Company Financial Performance Charts

Safe Orthopaedics SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Safe Orthopaedics SA, Key Information
Safe Orthopaedics SA, Key Ratios
Safe Orthopaedics SA, Share Data
Safe Orthopaedics SA, Major Products and Services
Safe Orthopaedics SA, History
Safe Orthopaedics SA, Key Employees
Safe Orthopaedics SA, Key Employee Biographies
Safe Orthopaedics SA, Key Operational Heads
Safe Orthopaedics SA, Other Locations
Safe Orthopaedics SA, Subsidiaries
Safe Orthopaedics SA, Key Competitors
Safe Orthopaedics SA, SWOT Analysis
Safe Orthopaedics SA, Ratios based on current share price
Safe Orthopaedics SA, Annual Ratios
Safe Orthopaedics SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Safe Orthopaedics SA (SAFOR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Service Corporation International:企業の戦略・SWOT・財務分析
    Service Corporation International - Strategy, SWOT and Corporate Finance Report Summary Service Corporation International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Raiffeisen Switzerland Cooperative:企業の戦略・SWOT・財務情報
    Raiffeisen Switzerland Cooperative - Strategy, SWOT and Corporate Finance Report Summary Raiffeisen Switzerland Cooperative - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Harbin Gloria Pharmaceuticals Co Ltd (002437):企業の財務・戦略的SWOT分析
    Summary Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produces and markets nutritional drugs. The company’s products include pharmaceutical drugs for treating nutrition disorders, cancer, cardiovascular diseases, anti-tumor medication, respiratory medication, …
  • Enka Power:企業の戦略的SWOT分析
    Enka Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • ActiveCare Inc (ACAR):企業の財務・戦略的SWOT分析
    Summary ActiveCare Inc (ActiveCare) is a medical equipment company that monitors health analytics. The company provides monitoring component to traditional disease management and wellness solutions. It offers solutions such as diabetes supplies, online web-based administrative tools, browser and iPh …
  • Google LLC:企業の戦略的SWOT分析
    Google LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Southern Co (SO):電力:M&Aディール及び事業提携情報
    Summary Southern Co is a gas and electric utility holding company. It generates, distributes, markets and trades electricity and distributes gas. It uses a variety of sources for electricity generation including coal, oil and gas, nuclear and hydro. The company also distributes natural gas through t …
  • Koninklijke Ahold Delhaize N.V.:戦略・SWOT・企業財務分析
    Koninklijke Ahold Delhaize N.V. - Strategy, SWOT and Corporate Finance Report Summary Koninklijke Ahold Delhaize N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • The Wharf (Holdings) Limited
    The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sanofi Genzyme:企業の戦略・SWOT・財務情報
    Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report Summary Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • NNEGC Energoatom:企業の戦略的SWOT分析
    NNEGC Energoatom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • NantKwest Inc (NK):製薬・医療:M&Aディール及び事業提携情報
    Summary NantKwest Inc (NantKwest), a subsidiary of NantWorks LLC, formerly Conkwest Inc, is a clinical-stage immunotherapy company that develops therapeutic treatments for cancer, infectious diseases, and inflammatory diseases. The company utilizes its immuno-oncology NK platform to destroy the tumo …
  • Lidds AB (LIDDS):企業の財務・戦略的SWOT分析
    Summary Lidds AB (Lidds) is a developer of pharmaceutical products for the treatment of cancer and other diseases. The company offers Liproca Depot, an injectable product used for the treatment of prostate cancer. Its Liproca is a bioresorbable, biocompatible and locally injectable modified release …
  • SURFnet bv:企業の戦略的SWOT分析
    SURFnet bv - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Gritstone Oncology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Gritstone Oncology Inc (Gritstone) is a cancer immunotherapy company that focuses on the development of personalized cancer therapeutics. The company primarily concentrates on identifying and deploying the therapeutic neo-antigens from individual patients’ tumors for the development of novel …
  • PolyNovo Ltd (PNV)-医療機器分野:企業M&A・提携分析
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Ltd is a medical device company that develops, manufactures and commercializes biodegradable polymers for use in medical devices. The company offers products such as biodegradable temporizing matrix and negative pressure wound therapy dressing system …
  • Dowa Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Dowa Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Dowa Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Cardiva Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Cardiva Medical Inc (Cardiva) designs, develops and commercializes of vascular access management products. The major products of the company include VASCADE vascular closure system (VCS) for femoral arterial access site closure post-diagnostic and interventional endovascular procedures; and …
  • ADDvise Group AB (ADDV A):医療機器:M&Aディール及び事業提携情報
    Summary ADDvise Group AB (ADDvise), formerly ADDvise Lab Solutions AB, is a medical device company that manufactures and markets healthcare and laboratory equipment. The company offers laboratory products such as laboratory equipments, furnishings, safety ventilation, centrifuges, climate chambers, …
  • Graphic Packaging Holding Company:企業のM&A・事業提携・投資動向
    Graphic Packaging Holding Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Graphic Packaging Holding Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆